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Simple Summary: Neoplasia is a common cause of weight loss and emaciation. Despite its relative
infrequency in sheep, there are three neoplastic diseases with special relevance. Small intestinal
adenocarcinoma (SIA), ovine pulmonary adenocarcinoma (OPA) and enzootic nasal adenocarcinoma
(ENA) are three neoplastic diseases with economic impact in the sheep industry. They mostly occur
at ages under common production cycles, have epidemiological relevance in sheep rearing countries,
and two of them (OPA and ENA) have an infectious aetiology. SIA occurs elsewhere in the world but
has a special economic impact in Australia and New Zealand. OPA and ENA have relevant economic
significance in most continents but have not been recorded in Australia and New Zealand. In this
review, we focus on the epidemiology, clinicopathological features, pathogenesis and the diagnostic
tools currently available for the diagnosis of these three neoplastic diseases.
Abstract: We review three neoplastic wasting diseases affecting sheep generally recorded under
common production cycles and with epidemiological and economic relevance in sheep-rearing
countries: small intestinal adenocarcinoma (SIA), ovine pulmonary adenocarcinoma (OPA) and
enzootic nasal adenocarcinoma (ENA). SIA is prevalent in Australia and New Zealand but present
elsewhere in the world. This neoplasia is a tubular or signet-ring adenocarcinoma mainly located in
the middle or distal term of the small intestine. Predisposing factors and aetiology are not known,
but genetic factors or environmental carcinogens may be involved. OPA is a contagious lung cancer
caused by jaagsiekte sheep retrovirus (JSRV) and has been reported in most sheep-rearing countries,
resulting in significant economic losses. The disease is clinically characterized by a chronic respiratory
process as a consequence of the development of lung adenocarcinoma. Diagnosis is based on the
detection of JSRV in the tumour lesion by immunohistochemistry and PCR. In vivo diagnosis may
be difficult, mainly in preclinical cases. ENA is a neoplasia of glands of the nasal mucosa and is
associated with enzootic nasal tumour virus 1 (ENTV-1), which is similar to JSRV. ENA enzootically
occurs in many countries of the world with the exception of Australia and New Zealand. The
pathology associated with this neoplasia corresponds with a space occupying lesion histologically
characterized as a low-grade adenocarcinoma. The combination of PCR and immunohistochemistry
for diagnosis is advised.
Keywords: small intestinal adenocarcinoma; ovine pulmonary adenocarcinoma; jaagsiekte sheep
retrovirus; enzootic nasal adenocarcinoma; enzootic nasal tumour virus
1. Introduction
The relative infrequency of the occurrence of neoplasms in sheep seems to be apparent
specially when compared with infectious or parasitic diseases. However, an unbiased
prevalence and distribution data of tumours in sheep is difficult to obtain due to differences
in sheep breeds, geographical location, survey parameters and management systems all
around the world [1,2]. There is a paucity of published surveys, and they are mostly
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retrospective abattoir-based, academic or from diagnostic centres. In addition, the onset
of neoplasms increases with age, and sheep under common production cycles are culled
before the natural lifespan has elapsed [2]. Despite this, some types of ovine tumours occur
frequently in some countries where the sheep industry is important and appear during the
commercial lifespan of sheep.
Most neoplastic diseases cause weight loss and emaciation in the affected animal.
However, there are neoplastic wasting diseases affecting sheep with some particular aspects,
which give them a special consideration. We selected for this review three neoplastic
diseases: small intestinal adenocarcinoma (SIA), ovine pulmonary adenocarcinoma (OPA)
and enzootic nasal adenocarcinoma (ENA). These three diseases are mostly recorded at
ages under common sheep production cycles, up to 5–7 years. OPA and ENA are most
often detected in sheep that are 2–4 years of age, and SIA is mostly detected in animals
aged 5–7 years. The second characteristic is their epidemiological relevance with economic
impact in the sheep industry. Thus, OPA is endemic in countries such as Peru, Scotland,
South Africa and Spain, and SIA is highly prevalent in New Zealand and Australia [2].
The third element is the causative relationship with betaretroviruses for two of them, OPA
and ENA, which categorizes them as infectious diseases [3]. An additional interest of these
diseases is their similarities to respiratory or digestive human tumours, which make them
useful models for comparative oncology [4,5].
In this review, we focus on the epidemiology, clinicopathological features, pathogene-
sis and the diagnostic tools currently available for the diagnosis of these three neoplastic
diseases.
2. Small Intestinal Adenocarcinoma
Adenocarcinoma of the small intestine (small intestinal adenocarcinoma, SIA) is a
naturally occurring neoplasia of the small intestine of sheep which is highly prevalent in
some of the most important sheep-rearing countries.
2.1. Epidemiology
SIA is reported with high prevalence in some countries, such as New Zealand and
Australia, but is also commonly recorded in Scotland, Norway and Iceland; meanwhile,
sporadic cases have been reported from elsewhere in the world [2,6–9]. Although with
variations depending on the geographic area, prevalent figures obtained from abattoir
studies ranged from 0.2 to 1.6% in inspected adult sheep in New Zealand, Scotland and
Australia [6,7]. Therefore, this prevalence justifies the economic relevance of SIA for leading
sheep-rearing countries. Studies carried out in New Zealand and Australia described SIA
in Romney, Merino, British breeds and crosses with Merino [6,10–12], with a significantly
higher prevalence in British breeds [6]. However, SIA has been described in other breeds
elsewhere in the world, and not enough data are available supporting the fact that breed
is a risk factor for this neoplasia. SIA occurs at all ages but is mostly recorded in animals
5–7 years old [10–13], under the age of common sheep production cycles.
2.2. Clinical Features and Pathology
In most studies, recorded cases of SIA did not include clinical descriptions of the
affected sheep because they were dead when examined or the investigations were abattoir
based. In studies where clinical descriptions were detailed, first signs were not specific,
and sheep looked dull, separated from the mob during delivery, walked with a rolling
gait, showed signs of constipation and eventually died [12]. Some animals developed
abdominal pain, distension, ascites [9,10,12,13] and paracentesis demonstrated by large
amounts of clear fluid [12]. In many cases, sheep bearing SIA are not clinically detected
and animals only show a graduate loss of appetite and weight during a variable period
ranging from a few weeks up to six months [9,12,13].
At post-mortem examination, clinically affected sheep showed emaciation together
with variable degrees of ascites: from 200 mL to several litres of yellowish fluid [9,10,13].
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The edema fluid can be extended to the thoracic cavity [13]. One streaking feature observed
at necropsy was the location of the tumour. The primary site of the tumour was in most
cases in the middle third of the small intestine (jejunum), followed by the distal third and
more rarely in the duodenum [4,9–11,13]. The tumour was identified by the presence, at
those sites, of a dense, firm and white mass extending over serous surfaces of the intestine
along the mesentery [4,9–11,13] (Figure 1A).
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Figure 1. Gross pathology and histopathology of the small intestinal adenocarcinoma. (A) Sheep 5 years old. Serous
surface on distal third segment of the small intestine. Firm and white mass extending over serosa of convoluted intestinal
segment. Plaited whitish cords are extended on the mesentery. (B) Sheep 5 years old. Section of the intestine showing
single polypoid pedunculated mass causing stricture. Lumen of the intestine greatly dilated is observed proximal to the
mass. (C) Histopathology of an int stinal sample from A. Acin r and tubular structures of various sizes lined by cub idal or
columnar epithelial cells replace the intestinal mucosa. Small groups or cords of epith lial cells are also een. Moderate
desmoplastic reaction together with lymphocyte infiltration is observed. Hemat xylin-eosin. 200×. (D) Hi topathology
of an intestinal sample from B. Signet ring cells characterized by mucin-filled cytoplasm; peripheralized crescent-shaped
nuclei are numerous in this area of the tumour. Hematoxylin-eosin. 100×.
However, in many cases, disseminatio beyon thes sites has occurred, reaching
other organs such as the tomach or liver, and it is i entified by white spots, plaques
or diffuse sh ets of den tissue rising above the ffected areas [4,10,11,13]. Occasion-
ally, similar picture can be observed over the diaphragmatic ple ra and p icardium [13].
The mesenteric lymph node chain as gen rally enlarged and much firmer than nor-
mal [10,11,13]. Lymph n de m tastases were detect d in the majority of tumours [4]. In
advanced cases, when sections wer obtained from affected areas of the inte tine, th wall
showed a thick firm white layer replacing serous c at, and the lumen was filled either
with yellowish gelatinous substance blood stai ed or large clots of blood causing complete
obstruction [10,11]. Longitudinal sections of the intestine of early and advanced cases
showed single or multiple polypoid masses with thick peduncle projecting into the lumen
causing variable degree of obstruction [4,10,11,13]. Proximal to the stricture, the lumen of
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the bowel was greatly dilated and filled with digesta [4,9–11,13], and distal to this point,
the small and large intestine contained little or no food material [11] (Figure 1B).
The histopathology of the SIA has been studied by several authors, and descriptions
are very similar among different countries [4,7,9,10,13]. Intestinal architecture is remarkably
altered and tumour cells varying in size are present through all layers of the intestinal wall
and follow an acinar pattern or are in the form of closely packed cells [4,10]. Neoplastic
cells are large, moderately pleomorphic, polyhedral cells with well-defined borders. Cells
contain a large, round and central nucleus with prominent nucleoli. Cell cytoplasm includes
variably sized vacuoles that often contain mucus [4,7]. There is coexistence between more
differentiated types of epithelial cells, such as enterocytes and goblet cells organized in
acini, or in tubular fashion with less differentiated types in closely packed cells [8–10].
Generally, SIA is histologically graded as moderate or poorly differentiated [4]. In addition,
groups of signet-ring cells are also seen, but they are not a prominent feature in most
descriptions [4,9,10,13]. Mitotic figures are rare [8] and have been estimated in 2–5 mitosis
per high power field. Necrosis is a common event [4] (Figure 1C,D).
The latest histologic classification of SIA in WHO histologic classification of tumours
of the lower alimentary tract indicates that signet-ring cell carcinoma is the most frequent
pattern [14]. Signet-ring cell carcinoma is defined in the same publication as a malignant
epithelial tumour which is composed in more than a half of these cells. However, although
signet-ring cells can be part of the cells composing the SIA, several authors indicate that
these cells are present in all tumours, but they are not a predominant feature of the SIA in
sheep, and signet-ring cells are very few in sheep tumours [4,8,9,13]. Some authors have
indicated that SIA of sheep have features of several types of histological patterns listed on
the WHO classification of 1976 [15], and the most appropriate description for SIA is that of
tubular adenocarcinoma [8,9].
2.3. Risk Factors
The predisposing factors or aetiological relationship of the SIA are not known. The
high prevalence found in some geographic areas, such as New Zealand, indicates a link
with environmental carcinogens or genetic predisposition. Thus, in some epidemiological
studies, the tumour was more prevalent in British breeds than in fine wool sheep, or in
areas with increased density [6,16]. This genetic predisposition has also been suggested
in reports of cases of closely related sheep in one flock [17]. In other studies, exposure
to herbicides (phenoxy and picolinic acid) has been associated with a significant increase
in the rate of SIA in some breeds [16]. Despite these studies, no conclusive evidence
of the relationship of SIA with either genetic factors or environmental carcinogens has
been found.
SIA has not been found to be associated with frequent infections, such as herpesviruses,
Helicobacter spp. or Mycobacterium avium subsp. paratuberculosis [18], and screening for
virus production in explant cultures from sheep SIA cells proved negative [19]. In addition,
the presence of Bacteroides fragilis toxin gene, a molecular marker of colonic carriage of
enterotoxigenic Bacteroides fragilis (ETBF) in humans, which is related to colon cancer, was
investigated in SIA. There was no apparent association between the carriage of ETBF and
the presence of SIA [20].
SIA has been proposed as a model of human intestinal cancer [4], and some studies
have indicated an altered expression of important proteins also dysregulated in human
colon cancer [21]. However, studies in SIA on the expression of mismatch repair proteins
do not support that germline defects in their corresponding genes are predisposing factors,
as happens in human colon cancer [22].
2.4. Diagnosis
There are no clinical diagnostic tests for SIA, and the confirmation requires histopatho-
logical analysis of the tumour samples.
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3. Ovine Pulmonary Adenocarcinoma
Ovine pulmonary adenocarcinoma (OPA, ovine pulmonary carcinoma, sheep pul-
monary adenomatosis and jaaagsiekte) is a contagious lung cancer of sheep caused by
jaagsiekte sheep retrovirus (JSRV) [23,24]. The disease, which is invariably fatal, is a
wasting disease clinically characterized by an afebrile progressive respiratory condition
as a consequence of the development of lung adenocarcinoma, since JSRV induces the
neoplastic transformation of secretory epithelial cells of terminal bronchioles and alve-
oli [25,26]. OPA has been reported in many of the sheep-rearing areas of the globe and
causes significant economic losses, as the implementation of effective strategies for the
control and eradication is not an easy task due to the lack of vaccines and the difficulty
in identifying preclinical stages and, specially, lesion-free infected animals [27,28]. No
vaccines for OPA have been developed yet. An unusual feature of JSRV infection in sheep
is the absence of detectable antibody or T cell responses following natural or experimental
infection. However, antibodies specific for JSRV capsid protein were induced by inocu-
lation of recombinant proteins in adjuvants. Studies are underway to characterize and
improve these responses and to determine whether they are protective against infection
with JSRV and/or the development of OPA [27].
3.1. Epidemiology of OPA and JSRV Infection
The first descriptions of OPA were made more than 100 years ago in South Africa and
Britain and, since then, the disease has been reported in many countries elsewhere in the
world with the exception of Australia and New Zealand. The disease was eradicated in
Iceland in the 1950s by drastic slaughter measures [26].
Under natural conditions, clinically apparent OPA mostly appears in animals 1–4 years
old, although the disease can occur at all ages, and there is no clear evidence of sex or
breed susceptibility [25]. The incubation period for the development of clinical disease
following natural infection may last from months to years, but is shorter (6–8 months)
in flocks where OPA is not endemic. On the other hand, when very young lambs are
experimentally infected, clinical signs tend to appear in 3–6 weeks or even before [25,26].
The mortality rate in OPA affected flocks varies depending on how long the infection
has been present. In the first years after introduction, the infection mortality rates can
reach 30–50% (as during the OPA epidemics in Iceland in the 1930s), but rates drop to
1–5% when the disease becomes endemic [25,27]. The prevalence of OPA appears to vary
between countries and is endemic in some of them, such as Peru, Scotland, South Africa
and Spain [26]. A study conducted in a Spanish abattoir recorded visible OPA lesions in
0.3–1.4% of sheep slaughtered in a year [29], and high figures were also obtained in an
abattoir study in Edinburgh [30], indicating that OPA prevalence may be underestimated.
Results from a longitudinal survey in two OPA endemic flocks carried out in Scotland
are in accordance with this. Around 30% of the sheep had histologically confirmed OPA
lesions, but the annual losses attributable to OPA varied between 2 and 10% [26]. These
findings were obtained by clinical observation and histopathological analysis and, there-
fore, do not reflect the prevalence of JSRV infection in OPA-affected flocks. The lack of a
detectable specific immune response against JSRV in infected animals [31,32] prevented
the development of serological tests, and the acquisition of certain knowledge about this
issue was not possible till the arrival of molecular techniques for the specific detection of
JSRV, which demonstrated the tissue distribution of the virus outside the OPA lesion [33].
In this way, JSRV proviral DNA could be detected by PCR in lymphoid tissues and pe-
ripheral blood mononuclear cells (PBMC) in clinically OPA affected sheep, in animals
with preclinical OPA lesions and in lesion-free infected animals [34–38]. The PCR test
for the detection of JSRV proviral DNA in blood cells has been used in epidemiological
studies, pointing to an incidence of JSRV infection in OPA-affected flocks much higher
than previously believed [36,38]. In a study in which a Spanish commercial flock was
tested periodically over three years, at the end of the study, the virus had been detected
in 50% of the animals [38]. JSRV could be detected in animals of all age ranges, but the
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highest incidence (80%) was found in animals that were under one year old when the study
began [38]. Despite this, only a minority of animals that tested positive developed OPA
lesions (17%), many of which were subclinical, since 40% of animals with OPA lesions
at necropsy were not clinically affected [38]. This is in accordance with a previous study
indicating that many OPA cases can remain subclinical at the end of the sheep’s commercial
lifespan, and induction of OPA is not a common outcome of naturally occurring JSRV
infection [36].
It is generally accepted that the respiratory route is the most important natural mode
of transmission for JSRV [25]. In recent years, the contribution of colostrum and milk
(C/M) to the spread of infection in commercial sheep farms has also been investigated.
Epidemiological studies demonstrated that JSRV infection can occur perinatally or in
the first few months of life in lambs [36,38], and the prevalence of JSRV infection in this
age range can be particularly high in commercial flocks, with 30% of lambs destined for
replacement found to be JSRV blood positive in one single PCR test [38]. In addition, a
survey carried out in a flock with a high prevalence of OPA showed that an important
reduction in the incidence of the disease was possible by creating a new flock with lambs
separated at birth from their mothers and reared artificially, suggesting that C/M could
be relevant for the transmission of JSRV under natural conditions [39]. Further studies
demonstrated that colostrum and milk can transmit JSRV to lambs. The presence of JSRV
proviral DNA was demonstrated in somatic cells from colostrum in sheep belonging to
OPA-affected flocks, and the JSRV provirus was detected in the blood of lambs artificially
fed with infected C/M [40]. Evidence of the relevance of this route of JSRV transmission
to lambs under natural conditions has been provided by the detection of JSRV in Peyer’s
patches and/or mesenteric lymph nodes in 25% of the lambs (between 12 h and 10 days
of live) naturally fed by blood infected but asymptomatic ewes [41]. To date, no other
details of this way of transmission for JSRV are known. Based on current data, this route of
transmission should be taken into account in the design of control strategies, although the
possibility that C/M transmission of JSRV to lambs can result in OPA development has not
been explored yet.
3.2. Clinical Features and Pathology
OPA clinically affected sheep show signs of progressive afebrile respiratory disease
associated with cachexia caused by the growth of lung adenocarcinoma. When the lung
tumour is very small, the disease is subclinical, but as the tumour becomes extensive
enough to interfere with lung function, dyspnoea and moist respiratory sounds caused
by the accumulation of fluid in the respiratory airways are detected [25]. In the final
stages of the disease, variable amounts of frothy sero-mucous fluid (from 10–40 mL to
as much as 400 mL) [25,42] are discharged from the nostrils when the hindquarters are
raised (“wheelbarrow” test) or the head is lowered (Figure 2A), which is considered an
OPA characteristic sign [43]. Affected sheep remain alert, afebrile and have a good appetite,
but progressive loss of weight is evident, and death inevitably occurs within a few weeks
of the start of the clinical disease as a result of compromised respiratory function caused by
tumour enlargement. However, the clinical course can be shortened, and fever appears
if bacterial infections become superimposed. The concurrence of other diseases can also
affect the clinical outcome of the disease. Maedi-visna has been frequently reported, and it
results in a worsening of the clinical signs and a precipitation of the disease course [25].
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Figure 2. Ovine pulmonary adenocarcinoma (OPA): clinical signs and pathology. (A) Four year old sheep showing OPA
clinical signs. When head is lowered, froth sero-mucous fluid comes from the nostrils nd ours over the floor. (B) Post-
mortem examination of thoracic cavity. Classical OPA form. Left lung with cranio-ventral areas purple in colour and
consolidated. The r st of the lung shows an increase in v l me and is lighter in colour. (C) Right ca d l lung section.
Classical OPA. Lung section showing granular appearance foci and foamy fluid pouring from main airways. (D) Left
lung from a sheep showing atypical OPA form. Multiple white nodules of various sizes distributed throughout the lung
surface. (E) Section of lung from right caudal lobe. Atypical OPA. Multiple white nodules with various sizes: bigger ones
coalescing close to a central main bronchus and others expanding to close lung areas. (F) Histopathology of OPA lesion.
Alveolar epithelial cells proliferate following a lepidic pattern. Alveolar wall is replaced by cuboidal cells into a tubular
or papiliform pattern. Tumour stroma is infiltrated mainly by lymphocytes. Numerous macrophages are filling alveolar
lumens in the tumours and in the close areas. Hematoxylin-eosin. 100×. (G) Histopathology of OPA lesion. Bronchiole
with epithelium transformed into papiliform growth almost completely filling the lumen. Hematoxylin-Eosin. 100×.
(H) Immunohistochemistry using a mouse monoclonal antijaagsiekte sheep retrovirus envelope (JSRV Env) protein. Cellular
membranes and cytoplasms of neoplastic cells of a tumour nodule are labelled. In the adjacent alveoli, positive cells are
observed either isolated or in small groups. 100×.
Animals 2021, 11, 381 8 of 18
Two pathological forms of OPA have been described in the literature, classical and
atypical [25]. In the classical presentation, at necropsy, the lungs do no collapse when
the chest is opened and are enlarged. The neoplastic lesions can occur in any part of the
lungs, but cranio-ventral parts are more frequently involved. They are grey or purple
in colour, do no protrude significantly on the surface and have an increased consistency
(Figure 2B). The cut surface of the tumour lesion has a granular appearance and is moist,
and a frothy fluid pours from the bronchioles and bronchi with slight pressure (Figure
2C). Relatively often, this tumour lesion pattern may be overshadowed by concurrent
lesions of bacterial pneumonia, abscesses or maedi. In contrast with the classical form,
the atypical presentation tends to be more nodular in both early and advanced tumours.
The nodules may be solitary or multiple and mainly located in the diaphragmatic lobes.
They are pearly white in colour and have a very hard consistency (Figure 2D). A section
of the tumour lesions shows that they are very well demarcated from the surrounding
parenchyma, and their surface looks dry (Figure 2E). The tracheobronchial and mediastinal
lymph nodes may not show any visible changes or may be slightly or clearly enlarged, and
may occasionally present small metastases [25]. More rarely, metastases in distal organs,
such as the liver, kidney, heart, skeletal muscle, digestive tract, spleen, skin and adrenal
glands, have been observed [25,27,44]. Both forms, classical and atypical, may be present
in a flock and in individual sheep, and intermediate and mixed forms have been described.
Classical and atypical forms may represent two extremes of the disease spectrum, rather
than two separate forms. Descriptions of experimentally induced OPA are compatible
with the classical forms observed in natural conditions, but atypical forms have not been
reported in experimental conditions [25].
Histological examination of OPA natural cases reveals the presence of neoplastic
proliferation foci of epithelial cells in alveolar and bronchiolar areas. These proliferations
have a papillary and acinar appearance and expand into adjacent structures. In the alveolar
neoplastic regions, cuboidal or columnar cells replace the normal type II pneumocytes, but
the structure of the alveolar wall is maintained (lepidic growth) (Figure 2F). Concurrently,
polypoid ingrowths arise from the bronchiolar epithelium in affected terminal bronchioles
(Figure 2G). The stroma of the tumour is generally thin but may be infiltrated by variable
amounts of lymphocytes, plasma cells and connective tissue fibres. Macrophages are
consistently found in variable numbers surrounding neoplastic alveoli and affected bron-
chioles. Neutrophils can also be found, but they are interpreted as indicative of secondary
bacterial infections. In some cases, mesenchymal tissue foci (myxoid nodules or growths)
have been described admixed with the neoplastic epithelial component [25,27,45]. The
histopathological features of atypical OPA are essentially the same as those of classical OPA,
but a large number of inflammatory cells and connective fibres infiltrate the stroma. The
histological appearance of experimentally induced OPA closely resembles that of natural
cases [25].
3.3. Aetiology and Pathogenesis
Jaagsiekte sheep retrovirus is the causative agent of OPA [23,24]. This retrovirus infects
and induces the transformation of secretory epithelial cells of the distal respiratory tract of
sheep, and more rarely of goats and wild mouflon [25]. JSRV is an exogenous retrovirus
belonging to the genus Betaretrovirus and is highly related to enzootic nasal tumour virus
(ENTV) of sheep (ENTV-1) and goats (ENTV-2), which also causes an adenocarcinoma of
secretory cells of respiratory epithelia, but in the upper tract [46,47]. Interestingly, sheep
and goats, and other mammals, contain several copies of nonpathogenic JSRV-related
endogenous retroviruses (enJSRVs) integrated in their genome [48,49]. JSRV has the typical
genomic organization of a simple retrovirus, and contains the genes gag, pro, pol and env.
These genes, respectively, encode the proteins of the viral core (MA, CA, NC and others),
the viral protease (PR), the viral reverse transcriptase (RT) and integrase (IN) enzymes
and the glycoproteins of the viral envelope (the surface domain SU which interacts with
the cellular receptor and mediates cellular entry, and the transmembrane domain TM). In
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addition to encoding viral envelope proteins, the env gene of JSRV functions as a dominant
oncogene. Its sole expression is sufficient to induce cellular transformation [50,51], and the
cytoplasmic tail of the JSRV TM protein is essential for envelope-induced (Env-induced)
transformation [52]. Apart from these four common retroviral genes, JSRV has a further
open reading frame (orf-x) overlapping pol gene, whose role is unknown. Noncoding
regions are present at the ends of the genome: U5 is present at the 5′ end, U3 at the 3′ end
and the R region is repeated at both. Once JSRV interacts with a specific cellular receptor
to enter the cell (HYAL2) [53], and after reverse transcription of the viral genome into
double-stranded DNA, the viral DNA integrates into the host DNA to form a provirus.
During the process of reverse transcription, the noncoding regions at the ends of the
genome are duplicated and give origin to the viral long terminal repeats (LTRs), which
are major determinants of retrovirus tropism. JSRV can infect many cell types; in fact, it
establishes a disseminated infection of the lymphoid tissues of OPA affected sheep [33],
but the exogenous JSRV LTRs are particularly active in type II pneumocytes and Club cells
of the lung, the cells where the tumour develops [54].
The mechanisms involved in JSRV Env-induced transformation have not been fully
elucidated, but several studies have shown the activation of signalling pathways that
control cellular proliferation, including phosphatidylinositol 3-Kinase (PI3K)-Akt and
mitogen-activated protein kinase (MAPK) [3,55], and additional pathways, including the
AGR-2-YAPI-AREG axis, may also contribute to oncogenesis in this disease [55]. Other
mechanisms, such as targeted integration of JSRV, cannot be totally excluded [3].
OPA has several features in common with lung adenocarcinoma of humans, including
a similar histological appearance and activation of common cell signalling pathways, and
additionally, the size and organization of human lungs are much closer to those of sheep
lungs than to those of mice. This has led to the suggestion that OPA may be a valuable
large animal model for the human disease [5,56–58]. This model can be informative for
understanding cancer in humans and can identify and test the efficacy of new therapeutic
interventions in a high reproducible system [58].
3.4. Diagnosis
As stated above, diagnosis of clinical OPA is possible by the detection of moist res-
piratory sounds and the presence of frothy lung fluid emitted from the nostrils. The
overproduction of lung fluid is a characteristic clinical sign, and in the final stages of
classical OPA, variable amounts of nasal discharge are obtained when the rear limbs are
raised (“wheelbarrow” test) or the head is lowered. The diagnosis can be confirmed by the
detection of JSRV RNA in lung fluid samples using reverse transcriptase PCR [33]. How-
ever, not all cases of OPA produce this fluid in detectable amounts, such as the early OPA,
and also atypical OPA, even in advanced stages. In these cases, post-mortem examination
is needed for OPA diagnosis and gross pathology and histopathological changes described
above should be observed.
Lesions of OPA can be confirmed by immunohistochemical methods for the detection
of JSRV proteins, using antibodies against proteins encoded by gag and env genes [59,60].
Immunolabelling is associated with the cytoplasm of transformed alveolar and bronchiolar
cells (type II pneumocytes and Club cells, respectively) where JSRV replicates actively
(Figure 2H). In addition, JSRV proteins have been demonstrated in myxoid nodules and
also in the infiltrating lymphoreticular cells of some early OPA lesions [45].
JSRV proteins can be also detected in tumour homogenates by the Western blotting
technique [61]. In addition, OPA tumours are always positive when tested by PCR tech-
niques for the detection of JSRV genome [33]. These tests are based on the detection of
JSRV RNA by reverse transcriptase PCR, but JSRV proviral DNA can also be specifically
detected by PCR. In this case, primers are designed to amplify the U3 region of the JSRV
genomic sequence, in which major differences with JSRV-related endogenous retroviruses
that the sheep genome contains are located.
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However, in vivo identification of OPA preclinical cases and lesion-free infected an-
imals would be vital for the implementation of effective strategies for the control and
eradication of the disease. Unlike other ovine retroviral infections, such as visna-maedi
virus (VMV), the absence of a specific antibody response in JSRV infected animals [31,32]
has precluded the use of diagnostic serological tests. The design of PCR techniques for the
specific detection of JSRV provirus integrated in the sheep genome [33] revealed the pres-
ence of JSRV in lymphoid tissues and PBMC in clinically OPA affected sheep, in animals
with preclinical OPA lesions and in lesion-free infected animals [34–38] and opened the
door to the development of blood PCR tests for preclinical diagnosis of OPA. Although
this PCR blood test is very specific, it has low sensitivity and provides an inconsistent
detection of JSRV [35,37,38,62], probably due to the low proportion of infected cells in the
blood [63]. Therefore, this test is not suitable to test individual animals for accreditation
purposes but can be applied for the identification of infected flocks [37] and has been used
in epidemiological studies [36,38]. Other tests have been investigated in order to improve
the sensitivity in the detection of OPA preclinical cases. The same PCR test on bronchoalve-
olar lavage samples collected from live animals provides better results than the blood PCR
test for the detection of early OPA (early visible lesions and microscopic OPA), and its
sensitivity is 89% in comparison to the results of histological examinations [64]. However,
this test does not detect lesion-free infected animals which may develop the disease in the
future, and the practical difficulties in collecting the samples prevent its application at the
field level. PCR testing of bone marrow aspirates collected in asymptomatic infected sheep
has been attempted with negative results, although positively labelled cells were revealed
by immunohistochemical methods in bone marrow samples collected at necropsy [65]. The
same PCR when applied to colostrum and milk samples of JSRV blood positive lactating
ewes with no signs of OPA disease did not seem to be more sensitive than the blood PCR
test, and also provided an inconsistent JSRV detection throughout a lactation period [41].
Apart from PCR tests, transthoracic ultrasonography of both sides of the chest is another
method that has been investigated for the in vivo detection of OPA lesions, in an attempt to
eliminate this disease [66,67]. This test may be very helpful in reducing the OPA prevalence
in a flock by identification and culling of affected animals. However, the test currently
lacks sufficient sensitivity and specificity for the diagnosis of early stages of the disease. It
is not able to detect lesions smaller than 2 cm and cannot clearly discriminate some nodular
parasitic lesions or suppurative pneumonias that could be confused with OPA nodules.
A negative scan cannot provide a guarantee that the animal is free of JSRV infection nor
early OPA, and re-scanning is recommended in a short time, as tumours can develop
much faster (a few months) than previously thought [68]. Therefore, eradication of OPA
based only on this method seems to be unlikely. More recently, other approaches to detect
preclinical OPA have been tested, such as reverse transcriptase PCR tests on nasal swabs.
These seem to be more sensitive than the blood PCR test, but they have been proposed
at flock level, not for testing individual animals [69]. Tests based on biomarkers are also
in progress [69]. In this regard, in a recent study, levels of several tumour markers were
found to be significantly higher in the blood of sheep with clinically suspected OPA and
lesions confirmed by macroscopic and histopathological examination, than in lesion-free
animals [70]. These tumour markers are thought to facilitate the diagnosis of OPA, but its
possible usefulness in the diagnosis of subclinical OPA has not been investigated.
4. Enzootic Nasal Adenocarcinoma
Enzootic nasal adenocarcinoma (ENA, enzootic nasal tumour) is a contagious neo-
plasm of gland cells of the ethmoidal mucosa and is aetiologically associated with a
betaretrovirus. This retrovirus is known as enzootic nasal tumour virus 1 (ENTV-1), and it
is closely related but distinct to JSRV, which causes the ovine pulmonary adenocarcinoma,
and sheep endogenous retroviruses [46]. ENA has been experimentally reproduced in
sheep serving as a probe of the aetiological connection of ENTV-1 and this neoplasia [71].
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4.1. Epidemiology
ENA has been recorded in all major areas where sheep are farmed, with the exception
of Australia and New Zealand, and is apparently absent from the UK [72]. ENA has
also been described in goats and is associated with another betaretrovirus similar to JSRV
named enzootic nasal tumour virus of goats (ENTV-2) [47]. ENA in goats seems to be
expanding in China, and ENTV-2 isolates showed significant genetic differences from
reported European ones [73,74]. Pathological descriptions in these cases showed some
particular aspects which may be related to the differences observed between the Chinese
and European isolates [73,74]. In addition, a nasal adenocarcinoma in sheep associated
with JSRV but not with ENTV-1 has been recently reported in Ireland [75].
Epidemiological data indicate that ENA occurs enzootically but with a very variable
prevalence in affected flocks, ranging from 0.1–0.3% (low prevalence) to 2–15% (high
prevalence). In affected flocks, the disease is found mostly in animals between 2 and 4
years of age. In our experience, the most common presentation of ENA in sheep is as single
cases found from time to time in the same flock. However, in goats, frequently, a group of
diseased animals is detected at the same time. No genetic, sex or breed predisposition has
been reported [72].
4.2. Clinical Features and Pathology
In naturally diseased sheep, the first clinical signs are not clear breathing problems,
and a small amount of sero-mucous fluid emerging from the nostrils (unilaterally or
bilaterally), dripping continuously from them, is the only detected change. As the disease
progresses, more clear respiratory distress is observed with a variable amount of sero-
mucous fluid stuck and bubbling around the nostrils when breathing. As respiration
becomes more impaired by the tumour growth, snoring, coughing, sneezing, head shaking
and mouth-breathing are seen. The increasing and continuous secretion of fluid causes a
characteristic depilation on the area close to the upper lips (washed nose) (Figure 3A). As
the tumour originates in the ethmoidal area, it expands either cranially inside the nasal
cavity or laterally pressing close anatomical structures. As a result of this, close cranial
bones are shown to be soft or atrophic, and the overlaid skin may protrude and eventually
fistulize. Together with these changes, exophthalmos, as a consequence of the pressure
on the retroocular structures, can be seen. In some cases, the tumour penetrates into the
frontal sinuses expanding the cranial areas affected, and when tumours are bilateral, the
clinical picture is much worse. The animals remain active and with a good appetite, and
fever is usually not observed until near the time of death. Body condition is gradually
lost, and animals become emaciated and eventually die due to septicaemic or toxaemic
complications. The duration of the disease from the appearance of clinical signs to death
has been reported to vary from 3 weeks to 9 months [72].
ENA has been experimentally reproduced in young lambs by nebulization of a mix of
cell-free tumour extract. One of the infected lambs developed clinical signs similar to those
described in spontaneous disease. Computer tomography showed a bilateral soft density
tissue mass with poorly defined margins and few pinpoint areas of mineralization. The
mass was causing destruction of the bony cartilages and nasal turbinates, filling around
50% of nasal cavity and associated with the accumulation of fluids within air spaces and
sinuses [71].
Naturally occurring ENA has the characteristic clinical pattern described but can
be confused clinically with other diseases, such as chronic proliferative rhinitis (CPR),
oestrosis or other chronic bacterial or fungal infections. CPR is associated with Salmonella
enterica subsp. Diarizonae, and the main lesion may look like a tumour, but lesions are
mostly located in ventral turbinates and almost never in ethmoidal ones as in the case of
ENA [76].
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Figure 3. Enzootic nasal adenocarcinoma (ENA) clinical signs and pathology. (A) Sheep 3 years old. Right nasal nostril
showing sero-mucous fluid discharge. As a consequence, right nostril looks cleaner and less hairy (washed nose). (B) Sheep
4 years old. Sagittal section of the skull showing replacement of normal ethmoidal turbinate by a multinodular or polypoid
mass covered by mucus pressing close structures. (C) Histopathology of ENA. Epithelial cells proliferate into acinar and
tubular patterns in inner parts; meanwhile, external zones s ow a predominant papillary patter . Hematoxylin-Eosin.
100×. (D) Histo ogical section of ENA. Immunohistochemistry. Mo ocl nal antibody against JSRV Env protein. Positive
material is almost exclusively located on the apical membranes of both types of growths. 100×.
When performing the necropsy of the sheep with naturally occurring ENA, a sagittal
section of the skull following the projection of nasal septum will result in optimal inspection
of the nasal chambers. When opened, a tumour mass arising from the ethmoidal mucosa
and effacing the normal architecture of the ethmoidal conchae is observed (Figure 3B).
Tumours are generally multilobular, granular or soft surface; grey or reddish-white in
colour; and can be found unilaterally, bilaterally, expanded on close areas or penetrating
into nasal or frontal sinuses. On occasion, nasal septum and cribriform plates are eroded,
but this is not a common finding. Tumours are found together with nasal inflammatory
polyps in some cases, or containing areas of necrosis or purulent inflammation [72,77].
The microscopic architecture of the tumours is similar in all natural cases examined by
us and joins the characteristics of a low grade adenocarcinoma of nasal glands [72]. Light
microscopy reveals epithelial secretory cells proliferating into acinar, tubular, papillary or
even solid patterns. Inner parts of the tumours look more tubular or acinar; meanwhile,
external zones show a clear papillary pattern (Figure 3C). Apart from some areas of
cellular atypia or local invasion, no signs of malignancy are seen, and the mitotic index
is low. In addition, metastases in regional lymph nodes or in other organs have not
been recorded. The stroma is very scanty but infiltrated, either scattered or grouped, by
lymphocyte/plasma cells. Electron microscopy and histochemical studies have revealed
that neoplastic cells, in general, correspond to serous, mucous or mixed gland cells and
seem to originate either in olfactory or respiratory mucosal glands [72]. Glycohistochemical
characterization of histologically normal nasal mucosa and ENA supports the suggestion
that the tubular growth originates from the olfactory mucosa, whereas the papillary growth
Animals 2021, 11, 381 13 of 18
originates from respiratory mucosa. It is also indicated that goblet cells may have a role in
the histogenesis of the papillary portion of ENA in sheep [78].
In the case of experimentally induced ENA, two separate components are described.
The first type is characterized by an adenosquamous neoplastic proliferation and the second
type by a papillary neoplastic growth. Both have an outer layer of differentiated stratified
squamous epithelium. In the first type, the epithelium is connected with underlying
glandular epithelial cells in proliferation that make up most of this component. The
neoplastic glandular cells have a low mitotic index and slight degree of anisocariosis. The
second region has a papillary appearance, and under the epithelium abundant fibrous
tissue is observed [71].
4.3. Aetiology and Pathogenesis
ENTV-1 is a type of betaretrovirus demonstrated in ENA natural sheep tumours [79],
and genomic sequence studies comparing it with ENTV-2 and JSRV concluded that
these retroviruses are very similar but distinct and from JSRV-related endogenous retro-
viruses [46,80]. ENTV-1 showed a small number of differences, and comparison studies of
the nucleotide and amino acid sequences of viral genes revealed that ENTV-1 from North
America was highly homologous to the European isolates [80]. Thus, it seems that ENTV-1
shows little genomic variation, and it shares common pathogenic mechanisms with JSRV
and ENTV-2. In this regard, these three viruses interact with mammalian cells through
the HYAL2 (hyaluronglucosaminase 2) receptor for virus attachment and entry and can
infect different cell types. HYAL2 is a ubiquitous membrane surface protein that belongs to
hyaluronidases. However, ENTV-1 active replication is mostly restricted to nasal cavity
epithelia where viral long terminal repeats (LTRs) are active. This active replication of the
virus is important, because their oncogenic properties are due to envelope proteins. Several
in vitro experiments have indicated that JSRV and ENTV-1 share common mechanisms
of cell transformation. JSRV and ENTVs env gene products clearly activate a number of
proteins involved in signalling cascades controlling cell growth and fate, such as Protein
Kinase B (Akt) or Mitogen activated kinase (MAPK) signalling pathways, inducing perma-
nent activation of these tyrosine kinase cell signalling routes and disturbing the control of
cell growth and survival, leading to a growth advantage of deregulated cells. In spite of
this, other mechanisms leading to transformation, such as targeted integration of the virus
genome, cannot be totally ruled out [3,72].
4.4. Diagnosis
We have learnt that ENTV-1 is very similar to related endogenous and exogenous
betaretroviruses, and these similarities would represent a problem in trying to develop
reagents to identify specifically each of them. However, ENTV-1 showed the largest region
of sequence divergence in the LTR, particularly in U3 [46,79,80], and several specific PCRs to
amplify part of the LTRs regions have been developed to detect ENTV-1 genome [47,80,81].
Proviral DNA U3 PCR has been used in the analysis of the tissue distribution of ENTV-1 in
diseased animals, and the virus is rarely found out of the tumour and not in PBMC [47].
We may conclude from these results that ENTV-1 is mainly confined to the tumour, and the
likelihood of detecting the virus in PBMC is very low. Thus, a PCR blood test would not be
reliable as a preclinical test or for the detection of ENTV-1 infection.
Specific RT-PCRs (U5 and gag regions) from North American ENTV-1 isolates per-
formed on nasal exudates have been proposed as a part of an ante-mortem diagnostic test
for ENA surveillance and eradication programs. In this study, RT-PCR on nasal swabs was
correlated with pathology [81]. Therefore, ENTV-1 can be diagnosed by PCR in animals
showing clinical signs or with tumours at very early stages, but detection of only infected
animals is not currently possible.
The evaluation of the serological immune response in sheep with ENA has been
limited and controversial. Studies using Western blotting found reactivity to recombinant
JSRV capsid protein (JSRV-CA), as a Glutathion S-transferase (GST) fusion protein, in sheep
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sera from diseased animals. However, this reaction could be abolished completely by
absorption with the GST fusion partner but not with JSRV-CA. This suggested that the
activity recognized against this recombinant JSRV-CA was not specific [31]. In addition,
Western blotting techniques also failed to detect any antibody against viral antigens from
concentrated ENA fluid (De las Heras, unpublished results). A recent study identified
ENTV-1 reactivity by ELISA and Western blot in sheep serum from ENA affected and
in contact sheep belonging to a flock with high incidence of ENA. Serum samples were
tested for reactivity against recombinant ENTV-1 capsid and surface subunit (Env) proteins
produced using a polyhistidine tag (His-tag) bacterial expression system and removing
His-tag prior to use it as an antigen. Results showed that reactive antibodies against
both capsid and Env proteins could be detected in the serum of sheep either with or
without tumour evidence using ELISA and Western blot analysis. Both techniques detected
immune reactive antibodies against Env protein from the flock with a history of ENA
but not in the naive sheep serum samples. Furthermore, some samples from these sheep
were also positive to a neutralization test of ENTV-1 Env-pseudotyped virions. These
results suggest that these interactions were indeed specific and that sheep are able to
develop antibodies against the ENTV-1. In spite of this, ELISA and virus neutralization
tests showed low specificity and sensitivity, and they are unreliable to be used to diagnose
ENTV-1 infection [81]. Similar results have been obtained in sheep experimentally infected
with ENTV-1 [82]. In any case, this is a very relevant finding because it means that sheep
may not be immune tolerant to exogenous ENTV-1 infection as previously thought. Studies
on cell-mediated immunity to ENTV-1 have not yet been reported [72].
Although ENTV-1 and JSRV are distinct viruses, translation and alignment of open
reading frames suggest a very high degree of homology between them [79]. The similarity
between the coding regions of these retroviruses is in agreement with the evidence that
antisera against Env proteins of JSRV cross-reacted with ENTV-1 [60]. Thus, monoclonal
antibodies (Mab) against the surface domain of the JSRV envelope protein (Env) were
generated. Two of them (Clones C9 and B3) gave intense immunolabelling of lung tumours
in sheep infected with JSRV, and in mice exposed to an adenoviral vector encoding Env
(replication-defective adeno-associated virus type 6). These monoclonal antibodies recog-
nized tumours in all JSRV-infected sheep examined but not any cross-reacting antigens
in lung samples with a variety of diseases that were not the result of JSRV infection [60].
In addition, these antibodies also labelled tumour cells in mouse lung tumours induced
by the same adenoviral vector encoding ENTV-1 envelope protein and in natural cases of
ENA in sheep [60] and goats (De las Heras, unpublished results). Together, these results
indicate that antibodies are highly specific for Env proteins of ovine betaretroviruses (JSRV,
ENTV-1 and ENTV-2) and may provide a useful diagnostic test for these retroviruses using
immunohistochemical (IHC) methods in contagious respiratory tumours of sheep and
goats.
These monoclonal antibodies for Env proteins have been used to study nasal smears
for the detection of ENTV-1. Although ENTV-1 infected cells could be identified by
IHC staining of nasal smears, the specificity and sensitivity were low [81]. In tumour
sections, Env staining appears to be almost exclusively localized to the apical membrane
as opposed to that in OPA sections, which also appears at high levels in the cytoplasm of
tumour cells [60] (Figure 3D). More recently, another JSRV Env monoclonal via peptide
synthesis was generated, and assays demonstrated that it was able to recognize OPA
tumours [83]. This finding adds a new resource of reagents which may be used in these
contagious respiratory tumours associated with betaretroviruses in small ruminants. The
inconvenience of the use of IHC for ENA diagnosis is that all of these reagents are not
commercially available.
Finally, we would like to indicate that using this Mab, cross reactions between OPA and
ENA in sheep samples have to be taken into account in the IHC analysis and interpretation.
Thus, we have to consider that the coexistence of JSRV infection and ENA in sheep has
been reported, JSRV proviral DNA was detected in ENA tumour samples [84] and nasal
Animals 2021, 11, 381 15 of 18
adenocarcinoma associated with JSRV but not with ENTV-1 has been described in sheep
in Ireland [75]. Therefore, the possibility of coinfection with JSRV and the identification
of nasal tumours with morphological similarities to ENA but related with JSRV and not
ENTV-1 in sheep shows the necessity of using PCR in combination with IHC to reach an
accurate diagnosis of ENA.
5. Conclusions
Several neoplastic diseases deserve attention as causes of weight loss and emaciation
in sheep. SIA affects the gastrointestinal area and has epidemiological and economic
relevance in Australia and New Zealand, but is also present elsewhere in the world.
However, the aetiology is not known, and more investigation efforts are needed to clarify
which factors are clearly related to it. OPA is present in most sheep-rearing countries and
causes significant economic losses. The disease is a contagious lung cancer caused by the
oncogenic betaretrovirus JSRV, and diagnosis is based on the virus detection in the tumour
lesion by PCR and immunohistochemical methods. There are no serological diagnostic
tests due to the lack of a detectable immune response in JSRV infected animals, and
although several tests have been attempted for the diagnosis in live animals, they are not
sensitive or specific enough for the detection of early stage and lesion-free infected animals.
Working on improving early diagnosis and the identification of infected animals is essential
for the implementation of effective strategies for OPA eradication. ENA is prevalent
in some areas, mainly in Europe and North America, and is also an infectious disease.
The betaretrovirus related with ENA (ENTV-1) can be detected using PCR techniques or
immunohistochemistry in live animals bearing tumours but cannot be detected at pre-
neoplastic stages. Immune response is occasionally detected in diseased animals, but no
serological diagnostic tests are available. More efforts should be made to investigate the
early stages of infection and dissemination in order to find a diagnostic test which can be
used in control and eradication plans.
Author Contributions: Investigation, M.D.l.H. and A.O.; writing—original draft preparation, M.D.l.H.
and A.O.; writing—review and editing, M.D.l.H., M.B. and A.O.; supervision, M.D.l.H. All authors
have read and agreed to the published version of the manuscript.
Funding: This work was funded by the Aragón Government and the European Social Fund (Con-
struyendo Aragón 2016–2020), grant number A15-17R.
Institutional Review Board Statement: Not applicable.
Informed Consent Statement: Not applicable.
Data Availability Statement: Not applicable.
Conflicts of Interest: The authors declare no conflict of interest.
References
1. Head, K.W.; Munro, R. Tumours. In Diseases of Sheep, 3rd ed.; Martin, W.B., Aitken, I.D., Eds.; Blackwell Science: Oxford, UK,
2000; pp. 381–386.
2. Else, R. Tumors of Sheep. In Diseases of Sheep, 4th ed.; Aitken, I.D., Ed.; Blackwell Publishing: Oxford, UK, 2007; pp. 443–448.
3. Monot, M.; Archer, F.; Gomes, M.; Mornex, J.F.; Leroux, C. Advances in the study of transmissible respiratory tumours in small
ruminants. Vet. Microbiol. 2015, 181, 170–177. [CrossRef] [PubMed]
4. Munday, J.S.; Brennan, M.M.; Jaber, A.M.; Kiupel, M. Ovine intestinal adenocarcinomas: Histologic and phenotypic comparison
with human colon cancer. Comp. Med. 2006, 56, 136–141. [PubMed]
5. Gray, M.E.; Sullivan, P.; Marland, J.R.K.; Greenhalgh, S.N.; Meehan, J.; Gregson, R.; Clutton, R.E.; Cousens, C.; Griffiths, D.J.;
Murray, A.; et al. Novel Translational Ovine Pulmonary Adenocarcinoma Model for Human Lung Cancer. Front. Oncol. 2019, 9,
534. [CrossRef] [PubMed]
6. Simpson, B.H. The geographic distribution of carcionomas of the small intestine in New Zealand sheep. N. Z. Vet. J. 1972, 20,
24–28. [CrossRef] [PubMed]
7. Ross, A.D. Small intestinal carcinoma in sheep. Aus. Vet. J. 1980, 56, 25–28. [CrossRef]
8. Ross, A.D.; Day, W.A. An ultrastructural study of adenocarcinoma of the small intestine in sheep. Vet. Pathol. 1985, 22, 552–560.
[CrossRef]
Animals 2021, 11, 381 16 of 18
9. Perez, V.; Corpa, J.M.; García Marín, J.F. Intestinal adenocarcinoma in sheep in Spain. Vet. Rec. 1999, 144, 76–77. [CrossRef]
10. Dodd, D.C. Adenocarcinoma of the small intestine of sheep. N. Z. Vet. J. 1960, 8, 109–112. [CrossRef]
11. Cordes, D.O.; Shortridge, E.H. Neoplasms of sheep: A survey of 256 cases recorded at Rakura animal health laboratory. N. Z. Vet.
J. 1971, 19, 55–64. [CrossRef]
12. McDonald, J.W.; Leaver, D.D. Adenocarcinoma of the small intestine of merino sheep. Aus. Vet. J. 1965, 41, 269. [CrossRef]
13. Ulvund, M.J. Occurrence of intestinal adenocarcinomas in sheep in the southwestern part of Norway. N. Z. Vet. J. 1983, 31,
177–178. [CrossRef] [PubMed]
14. Head, K.W.; Cullen, J.M.; Dubielzig, R.R.; Else, R.W.; Misdorp, W.; Patnaik, A.K.; Tateyama, S.; van der Gaag, I. Histological
Classification of Tumors of the Alimentary System of Domestic Animals; World Health Organization 2nd Series; Armed Forces Institute
of Pathology: Washington, DC, USA, 2003; Volume 5.
15. Head, K.W., XII. Tumors of the lower alimentary tract. Bull. World Health Organ. 1976, 53, 167–186. [PubMed]
16. Newell, K.W.; Ross, A.D.; Renner, R.M. Phenoxy and picolinic acid herbicides and small-intestinal adenocarcinoma in sheep.
Lancet 1984, 2, 1301–1305. [CrossRef]
17. Løken, T.; Bjørnstad, C.; Ersdal, C. Intestinal adenocarcinomas in three generations of sheep. Vet. Rec. 2012, 170, 54a. [CrossRef]
18. Munday, J.S.; Keenan, J.I.; Beaugie, C.R.; Sugiarto, H. Ovine small intestinal adenocarcinomas are not associated with infection
by herpesvirus, helicobacter species or Mycobacterium avium subspecies paratuberculosis. J. Comp. Path. 2009, 140, 177–181.
[CrossRef] [PubMed]
19. Norval, M.; Head, K.W.; Else, R.W.; Hart, H.; Neill, W.A. Growth in culture of adenocarcinoma cells from the small intestine of
sheep. Br. J. Exp. Path. 1981, 62, 270–282.
20. Keenan, J.L.; Aitchison, A.; Pearson, J.F.; Frizelle, F.A.; Munday, J.S. Detection of the Bacteroides fragilis toxin gene in sheep with
and without small intestinal adenocarcinoma. N. Z. Vet. J. 2019, 67, 329–332. [CrossRef]
21. Munday, J.S.; Brennan, M.M.; Kiupel, M. Altered expression of β-catenin, E-cadherin, cyclooxygenase-2, and p53 protein by ovine
intestinal adenocarcinoma cells. Vet. Pathol. 2006, 43, 613–621. [CrossRef]
22. Munday, J.S.; Frizelle, F.A.; Whitehead, M.R. Mismatch repair protein expression in ovine intestinal adenocarcinomas. Vet. Pathol.
2008, 45, 3–6. [CrossRef]
23. Palmarini, M.; Sharp, J.M.; De las Heras, M.; Fan, H. Jaagsiekte sheep retrovirus is necessary and sufficient to induce a contagious
lung cancer in sheep. J. Virol. 1999, 73, 6964–6972. [CrossRef]
24. DeMartini, J.C.; Bishop, J.V.; Allen, T.E.; Jassim, A.; De las Heras, M.; Voelker, D.R.; Carlson, J.O. Jaagsiekte sheep retrovirus
proviral clone JSRVJS7, derived from the JS7 lung tumor cell line, induces ovine pulmonary carcinoma and is integrated into the
surfactant protein A gene. J. Virol. 2001, 75, 4239–4246. [CrossRef] [PubMed]
25. De las Heras, M.; González, L.; Sharp, J.M. Pathology of ovine pulmonary adenocarcinoma. Curr. Top. Microbiol. Immunol. 2003,
275, 25–54. [CrossRef] [PubMed]
26. Sharp, J.M.; DeMartini, J.C. Natural history of JSRV in sheep. Curr. Top. Microbiol. Immunol. 2003, 275, 55–80. [CrossRef] [PubMed]
27. Griffiths, D.J.; Martineau, H.M.; Cousens, C. Pathology and pathogenesis of ovine pulmonary adenocarcinoma. J. Comp. Path.
2010, 142, 260–283. [CrossRef] [PubMed]
28. Ortín, A.; De las Heras, M.; Borobia, M.; Ramo, M.A.; Ortega, M.; Ruíz de Arcaute, M. Ovine pulmonary adenocarcinoma: A
transmissible lung cancer of sheep, difficult to control. Small Rumin. Res. 2019, 176, 37–41. [CrossRef]
29. Dualde, D. Estudios Sobre la Adenomatosis Pulmonary Ovina en España (Studies on Sheep Pulmonary Adenomatosis in Spain).
Ph.D. Thesis, Instituto de Estudios Turolenses, Consejo Superior de Investigaciones Científicas (CSIC), Teruel, Spain, 1966.
30. Mackay, J.M.; Nisbet, D.I. Jaagsiekte—A hazard of intensified sheep husbandry. Vet. Rec. 1966, 78, 18–24. [CrossRef]
31. Ortín, A.; Minguijón, E.; Dewar, P.; García, M.; Ferrer, L.M.; Palmarini, M.; González, L.; Sharp, J.M.; De las Heras, M. Lack of
a specific immune response against a recombinant capsid protein of jaagsiekte sheep retrovirus in sheep and goats naturally
affected by enzootic nasal tumour or sheep pulmonary adenomatosis. Vet. Immunol. Immunopathol. 1998, 61, 229–237. [CrossRef]
32. Summers, C.; Neil, W.; Dewar, P.; González, L.; van der Molen, R.; Norval, M.; Sharp, J.M. Systemic immune responses following
infection with jaagsiekte sheep retrovirus and in the terminal stages of ovine pulmonary adenocarcinoma. J. Gen. Virol. 2002, 83,
1753–1757. [CrossRef]
33. Palmarini, M.; Holland, M.H.; Cousens, C.; Dalziel, R.G.; Sharp, J.M. Jaagsiekte retrovirus establishes a disseminated infection of
the lymphoid tissues of sheep affected by pulmonary adenomatosis. J. Gen. Virol. 1996, 77, 2991–2998. [CrossRef]
34. González, L.; García-Goti, M.; Cousens, C.; Dewar, P.; Cortabarría, N.; Extramiana, A.B.; Ortín, A.; De las Heras, M.; Sharp,
J.M. Jaagsiekte sheep retrovirus can be detected in the peripheral blood during the pre-clinical period of sheep pulmonary
adenomatosis. J. Gen. Virol. 2001, 82, 1355–1358. [CrossRef]
35. Salvatori, D.; González, L.; Dewar, P.; Cousens, C.; De las Heras, M.; Dalziel, R.G.; Sharp, J.M. Successful induction of ovine
pulmonary adenocarcinoma in lambs of different ages and detection of viraemia during the preclinical period. J. Gen. Virol. 2004,
85, 3319–3324. [CrossRef] [PubMed]
36. Caporale, M.; Centorame, P.; Giovannini, A.; Sacchini, F.; Di Ventura, M.; De las Heras, M.; Palmarini, M. Infection of lung
epithelial cells and induction of pulmonary adenocarcinoma is not the most common outcome of naturally occurring JSRV
infection during the commercial lifespan of sheep. Virology 2005, 338, 144–153. [CrossRef] [PubMed]
Animals 2021, 11, 381 17 of 18
37. De las Heras, M.; Ortín, A.; Salvatori, D.; Pérez de Villareal, M.; Cousens, C.; Ferrer, L.M.; Cebrián, L.M.; García de Jalón, J.A.;
González, L.; Sharp, J.M. A PCR technique for the detection of jaagsiekte sheep retrovirus in the blood suitable for the screening
of ovine pulmonary adenocarcinoma in field conditions. Res. Vet. Sci. 2005, 79, 259–264. [CrossRef] [PubMed]
38. Benito, A.A. Estudio Sobre la Infección y Transmisión del Retrovirus Ovino Jaagsiekte en un Rebaño Ovino Afectado de
Adenocarcinoma Pulmonar Ovino (Study on Jaagsiekte Sheep Retrovirus Infection and Transmission in an Ovine Pulmonary
Adenocarcinoma Affected Flock). Ph.D. Thesis, University of Zaragoza, Zaragoza, Spain, 2010.
39. Voigt, K.; Kramer, U.; Brugmann, M.; Dewar, P.; Sharp, J.M.; Ganter, M. Eradication of ovine pulmonary adenocarcinoma by
motherless rearing of lambs. Vet. Rec. 2007, 161, 129–132. [CrossRef] [PubMed]
40. Grego, E.; De Meneghi, D.; Alvarez, V.; Benito, A.A.; Minguijón, E.; Ortín, A.; Mattoni, M.; Moreno, B.; Pérez de Villarreal, M.;
Alberti, A.; et al. Colostrum and milk can transmit jaagsiekte retrovirus to lambs. Vet. Microbiol. 2008, 130, 247–257. [CrossRef]
41. Borobia, M.; De las Heras, M.; Ramos, J.J.; Ferrer, L.M.; Lacasta, D.; DeMartino, A.; Fernández, A.; Loste, A.; Marteles, D.; Ortín,
A. Jaagsiekte sheep retrovirus can reach Peyer’s patches and mesenteric lymph nodes of lambs nursed by infected mothers. Vet.
Pathol. 2016, 53, 1172–1179. [CrossRef]
42. Cousens, C.; Thonur, L.; Imlach, S.; Crawford, J.; Sales, J.; Griffiths, D.J. Jaagsiekte sheep retrovirus is present at high concentration
in lung fluid produced by ovine pulmonary adenocarcinoma-affected sheep and can survive for several weeks at ambient
temperatures. Res. Vet. Sci. 2009, 87, 154–156. [CrossRef]
43. Sharp, J.M.; De las Heras, M. Contagious Respiratory Tumours. In Diseases of Sheep; Martin, W.B., Aitken, I.D., Eds.; Blackwell
Science: Oxford, UK, 2000; pp. 181–186.
44. Minguijón, E.; González, L.; De las Heras, M.; Gómez, N.; García-Goti, M.; Juste, R.A.; Moreno, B. Pathological and aetiological
studies in sheep exhibiting extrathoracic metastasis of ovine pulmonary adenocarcinoma (Jaagsiekte). J. Comp. Pathol. 2013, 148,
139–147. [CrossRef]
45. De las Heras, M.; de Martino, A.; Borobia, M.; Ortín, A.; Alvarez, R.; Borderías, L.; Gimenez-Más, J.A. Solitary tumours associated
with jaagsiekte retrovirus in sheep are heterogeneous and contain cells expressing markers identifying progenitor cells in lung
repair. J. Comp. Pathol. 2014, 150, 138–147. [CrossRef]
46. Cousens, C.; Minguijón, E.; Dalziel, R.G.; Ortín, A.; García, M.; Park, J.; González, L.; Sharp, J.M.; De las Heras, M. Complete
sequence of enzootic nasal tumour virus, a retrovirus associated with transmissible intranasal tumours of sheep. J. Virol. 1999, 73,
3986–3993. [CrossRef]
47. Ortín, A.; Cousens, C.; Minguijón, E.; Pascual, Z.; Pérez de Villareal, M.; Sharp, J.M.; De las Heras, M. Characterization of enzootic
nasal tumour virus of goats: Complete sequence and tissue distribution. J. Gen. Virol. 2003, 84, 2245–2252. [CrossRef] [PubMed]
48. Palmarini, M.; Hallwirth, C.; York, D.; Murgia, C.; de Oliveira, T.; Spencer, T.; Fan, H. Molecular cloning and functional analysis of
three type D endogenous retroviruses of sheep reveal a different cell tropism from that of the highly related exogenous jaagsiekte
sheep retrovirus. J. Virol. 2000, 74, 8065–8076. [CrossRef] [PubMed]
49. Palmarini, M.; Mura, M.; Spencer, T.E. Endogenous betaretroviruses of sheep: Teaching new lessons in retroviral interference and
adaptation. J. Gen. Virol. 2004, 85, 1–13. [CrossRef] [PubMed]
50. Maeda, K.; Palmarini, M.; Murgia, C.; Fan, H. Direct transformation of rodent fibroblast by jaagsiekte sheep retrovirus DNA. Proc.
Natl. Acad. Sci. USA 2001, 98, 4449–4454. [CrossRef] [PubMed]
51. Wootton, S.K.; Halbert, C.L.; Miller, A.D. Sheep retrovirus structural protein induces lung tumours. Nature 2005, 434, 904–907.
[CrossRef] [PubMed]
52. Palmarini, M.; Maeda, N.; Murgia, C.; De-Fraja, C.; Hofacre, A. A phosphatidylinositol 3-kinase docking site in the cytoplasmic
tail of the jaagsiekte sheep retrovirus transmembrane protein is essential for envelope-induced transformation of NTH 3T3 cells.
J. Virol. 2001, 75, 11002–11009. [CrossRef]
53. Rai, S.K.; Duh, F.M.; Vigdorovich, V.; Danilkovitch-Miagkova, A.; Lermann, M.I.; Miller, A.D. Candidate tumor suppressor HYAL
2 is a glycosylphosphatidylinositol (GPI)-anchored cell-surface receptor for jaagsiekte sheep retrovirus, the envelope protein of
which mediates oncogenic transformation. Proc. Natl. Acad. Sci. USA 2001, 98, 4443–4448. [CrossRef]
54. Palmarini, M.; Datta, S.; Omid, R.; Murgia, C.; Fan, H. The long terminal repeat of jaagsiekte sheep retrovirus is preferentially
active in differentiated epithelial cells of the lungs. J. Virol. 2000, 74, 5776–5787. [CrossRef]
55. Karagianni, A.E.; Vasoya, D.; Finlayson, J.; Martineau, H.M.; Wood, A.R.; Cousens, C.; Dagleish, M.P.; Watson, M.; Griffiths, D.J.
Transcriptional response of ovine lung to infection with jaagsiekte sheep retrovirus. J. Virol. 2019, 93, 21. [CrossRef]
56. Palmarini, M.; Fan, H. Retrovirus-induced ovine pulmonary adenocarcinoma: An animal model for lung cancer. J. Natl. Cancer
Inst. 2001, 93, 1603–1614. [CrossRef]
57. Mornex, J.F.; Thivolet, F.; De las Heras, M.; Leroux, C. Pathology of human bronchioloalveolar carcinoma and its relationship to
the ovine disease. Curr. Top. Microbiol. Immunol. 2003, 275, 225–248. [CrossRef] [PubMed]
58. Youssef, G.; Wallace, W.A.H.; Gagleish, M.P.; Cousens, C.; Griffiiths, D.J. Ovine pulmonary adenocarcinoma: A large animal
model for human lung cancer. ILAR J. 2015, 56, 99–115. [CrossRef] [PubMed]
59. Palmarini, M.; Dewar, P.; De las Heras, M.; Inglis, N.F.; Dalziel, R.G.; Sharp, J.M. Epithelial tumour cells in the lungs of sheep with
pulmonary adenomatosis are major sites of replication for Jaagsiekte retrovirus. J. Gen. Virol. 1995, 76, 2731–2737. [CrossRef]
[PubMed]
Animals 2021, 11, 381 18 of 18
60. Wootton, S.K.; Metzger, M.J.; Hudkins, K.L.; Alpers, C.E.; York, D.; DeMartini, J.C.; Miller, A.D. Lung cancer induced in mice by
the envelope protein of jaagsiekte sheep retrovirus (JSRV) closely resembles lung cancer in sheep infected with JSRV. Retrovirology
2006, 3, 94–108. [CrossRef]
61. Sharp, J.M.; Herring, A.J. Sheep pulmonary adenomatosis: Demonstration of a protein which cross-reacts with the major core
proteins of Mason-Pfizer monkey virus and mouse mammary tumour virus. J. Gen. Virol. 1983, 64, 2323–2327. [CrossRef]
62. Lewis, F.I.; Brulisauer, F.; Cousens, C.; McKendrick, I.J.; Gunn, G.J. Diagnostic accuracy of PCR for jaagsiekte sheep retrovirus
using field data from 125 Scottish sheep flocks. Vet. J. 2011, 187, 104–108. [CrossRef]
63. Holland, M.J.; Palmarini, M.; García-Goti, M.; González, L.; McKendrick, I.; De las Heras, M.; Sharp, J.M. Jaagsiekte retrovirus is
widely distributed both in T and B lymphocytes and in mononuclear phagocytes of sheep with naturally and experimentally
acquired pulmonary adenomatosis. J. Virol. 1999, 73, 4004–4008. [CrossRef]
64. Voight, K.; Brügmann, M.; Huber, K.; Dewar, P.; Cousens, C.; Hall, M.; Sharp, J.M.; Ganter, M. PCR examination of bronchoalveolar
lavage samples is a useful tool in pre-clinical diagnosis of ovine pulmonary adenocarcinoma (Jaagsiekte). Res. Vet. Sci. 2007, 83,
419–427. [CrossRef]
65. Borobia, M.; Ortín, A.; Ferrer, L.M.; Ramos, J.J.; Lacasta, D.; De las Heras, M. Cells infected with jaagsiekte sheep retrovirus are
detected in the bone marrow of asymptomatic sheep. Can. J. Vet. Res. 2014, 78, 237–240.
66. Cousens, C.; Scott, P.R. Assesment of transthoracic ultrasound diagnosis of ovine pulmonary adenocarcinoma in adult sheep. Vet.
Rec. 2015, 177, 366. [CrossRef]
67. Scott, P.R. Use of ultrasonographic examination in sheep health management- A general appraisal. Small Rumin. Res. 2017, 152,
2–9. [CrossRef]
68. Scott, P.R.; Dagleish, M.P.; Cousens, C. Development of superficial lung lesions monitored on farm by serial ultrasonographic
examination in sheep with lesions confirmed as ovine pulmonary adenocarcinoma at necropsy. Irish Vet. J. 2018, 71, 23. [CrossRef]
[PubMed]
69. Cousens, C. Diagnosis and Potential for Veterinary Control of OPA in UK Flocks. Results of Studies to Date. In Proceedings of the
9th International Sheep Veterinary Congress, Harrogate, UK, 22–26 May 2017.
70. Özcan, C.; Yildirim, S.; Huyut, Z.; Özbek, M. Selected tumour biomarker levels in sheep with pulmonary adenomatosis. J. Vet.
Res. 2020, 64, 39–44. [CrossRef] [PubMed]
71. Walsh, S.R.; Linnerth-Petrik, N.M.; Yu, D.L.; Foster, R.A.; Menzies, P.I.; Diaz-Mendez, A.; Chalmers, H.J.; Wootton, S.K.
Experimental transmission of enzootic nasal adenocarcinoma in sheep. Vet. Res. 2013, 44, 66. [CrossRef]
72. De las Heras, M.; Ortín, A.; Cousens, C.; Minguijón, E.; Sharp, J.M. Enzootic nasal adenocarcinoma of sheep and goats. Curr. Top.
Microbiol. Immunol. 2003, 275, 201–223. [CrossRef]
73. He, Y.; Zhang, Q.; Wang, J.; Zhou, M.; Fu, M.; Xu, X. Full-length genome sequence analysis of enzootic nasal tumor virus isolated
from goats in China. Virol. J. 2017, 14, 141. [CrossRef]
74. Zhai, S.L.; Lv, D.H.; Xu, Z.H.; Yu, J.S.; Wen, X.H.; Zhang, H.; Chen, Q.L.; Jia, C.L.; Zhou, X.R.; Zhai, Q.; et al. A Novel Enzootic
Nasal Tumor Virus Circulating in Goats from Southern China. Viruses 2019, 11, 956. [CrossRef]
75. Jahns, H.; Cousens, C. Nasal adenocarcinoma associated with jaagsiekte sheep retrovirus infection in a sheep. J. Vet. Diagn.
Investig. 2020, 32, 152–155. [CrossRef]
76. Rubira, I.; Figueras, L.; De las Heras, M.; Bueso, J.P.; Castells, E.; Climent, M.; Lacasta, D. Chronic proliferative rhinitis in sheep:
An update. Small Rum. Res. 2019, 179, 21–25. [CrossRef]
77. De las Heras, M.; Minguijón, E.; Ferrer, L.M.; Ortin, A.; Dewar, P.; Cebrian, L.M.; Pascual, Z.; García, L.; García de Jalón, J.A.;
Sharp, J.M. Naturally occurring enzootic nasal tumour of sheep in Spain: Pathology and associated retrovirus. Eur. J. Vet. Pathol.
1998, 5, 1–5.
78. Scocco, P.; Lepri, E.; Mercati, F.; Vitellozzi, G.; Mechelli, L.; Ceccarelli, P. Glycohistochemical characterization of histologically
normal nasal mucosa and enzootic nasal tumor of sheep. Am. J. Vet. Res. 2012, 73, 1128–1136. [CrossRef] [PubMed]
79. Cousens, C.; Minguijon, E.; Garcia, M.; Ferrer, L.M.; Dalziel, R.G.; Palmarini, M.; De las Heras, M.; Sharp, J.M. PCR-based
detection and partial characterization of a retrovirus associated with contagious intranasal tumors of sheep and goats. J. Virol.
1996, 70, 7580–7583. [CrossRef] [PubMed]
80. Walsh, S.R.; Linnerth-Petrick, N.M.; Laporte, A.N.; Menzies, P.I.; Foster, R.F.; Wootton, S. Full-length genome sequenze analysis of
enzootic nasal tumor reveals unusually high degree of genetic stability. Virus Res. 2010, 151, 74–87. [CrossRef] [PubMed]
81. Walsh, S.R.; Stinson, K.J.; Menzies, P.I.; Wootton, S.K. Development of an ante-mortem diagnostic test for enzootic nasal tumor
virus and detection of neutralizing antibodies in host serum. J. Gen. Virol. 2014, 95, 1843–1854. [CrossRef] [PubMed]
82. Walsh, S.R.; Stinson, K.J.; Wootton, S.K. Seroconversion of sheep experimentally infected with enzootic nasal tumor virus. BMC
Res. Notes. 2016, 9, 15. [CrossRef] [PubMed]
83. Liu, Y.; Zhang, Y.F.; Sun, X.L.; Liu, S.Y. Detection of Jaagsiekte sheep retrovirus in the peripheral blood during the pre-clinical
period of ovine pulmonary adenomatosis. Genet. Mol. Res. 2016, 29, 15. [CrossRef] [PubMed]
84. Ortín, A.; Pérez de Villareal, M.; Minguijón, E.; Cousens, C.; Sharp, J.M.; De las Heras, M. Coexistence of enzootic nasal
adenocarcinoma and jaagsiekte retrovirus infection in sheep. J. Comp. Path. 2004, 131, 253–258. [CrossRef] [PubMed]
